Searched over 200M research papers for "glucosa normal"
3 papers analyzed
These studies suggest that glucosamine supplementation does not affect normal glucose levels or glucose metabolism in healthy individuals or those with diabetes.
20 papers analyzed
Glucosamine (GlcN) is a popular dietary supplement primarily used to support joint health. Concerns have been raised about its potential impact on glucose metabolism, particularly in individuals with diabetes or those at risk of developing diabetes. However, a comprehensive review of the available scientific data suggests that glucosamine, when taken at typical doses, does not significantly affect fasting blood glucose levels, glucose metabolism, or insulin sensitivity in healthy individuals, those with diabetes, or those with impaired glucose tolerance.
Long-term clinical trials, including those involving subjects with type 2 diabetes or pre-diabetes, have shown that glucosamine supplementation does not significantly alter fasting blood glucose concentrations. These studies, which spanned up to three years, indicate that glucosamine does not adversely affect glucose metabolism in these populations.
In a study involving healthy adults, participants were given 1500 mg of glucosamine sulfate daily for 12 weeks. The results showed no significant differences in fasting serum insulin or blood glucose levels. Additionally, glucosamine supplementation did not affect plasma glucose levels during oral glucose tolerance tests (OGTT) conducted at various intervals throughout the study. This suggests that short-term glucosamine use at recommended dosages does not cause glucose intolerance in healthy individuals.
The concentration of glucosamine in normal human serum has been measured using various methods. Normal values range from 40 to 130 mg per cent, with variations depending on the method used. Elevated glucosamine levels have been observed in individuals with infections, advanced malignant diseases, and other pathological conditions. These findings highlight the importance of understanding the baseline levels of glucosamine in serum to better interpret any potential changes due to supplementation.
Current research indicates that glucosamine supplementation, at typical doses, does not significantly impact glucose metabolism or insulin sensitivity in healthy individuals or those with diabetes or pre-diabetes. Both long-term and short-term studies support the safety of glucosamine in terms of glucose tolerance. However, further research is needed to conclusively determine its effects, particularly in individuals with pre-diabetes. Understanding the normal concentration of glucosamine in serum can also provide valuable context for interpreting these findings.
Most relevant research papers on this topic